Association between the interleukin-1β gene (IL1B) C-511T polymorphism and the risk of diabetic nephropathy in type 2 diabetes: A candidate-gene association study

DNA and Cell Biology

Volumn 33, Issue 7, 2014, Pages 463-468

  Stefanidis, Ioannis ^a,b   Kreuer, Karsten ^b   Dardiotis, Efthimios ^a   Arampatzis, Spyridon ^c   Eleftheriadis, Theodoros ^a   Hadjigeorgiou, Georgios M ^a   Zintzaras, Elias ^a,d   Mertens, Peter Rene ^b  

^a UNIVERSITY OF THESSALY   (Greece)

^b OTTO VON GUERICKE UNIVERSITY   (Germany)

^c UNIVERSITY OF BERN   (Switzerland)

^d TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA FRAGMENT; INTERLEUKIN 1BETA;

AGED; ARTICLE; CAUCASIAN; DIABETIC NEPHROPATHY; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENOTYPE; HOMOZYGOTE; HUMAN; INHERITANCE; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; POPULATION GENETICS; PRIORITY JOURNAL; PROMOTER REGION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SINGLE NUCLEOTIDE POLYMORPHISM;

AGED; CASE-CONTROL STUDIES; DIABETES MELLITUS, TYPE 2; DIABETIC NEPHROPATHIES; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INTERLEUKIN-1BETA; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC;

EID: 84903270299     PISSN: 10445498     EISSN: 15577430     Source Type: Journal    
DOI: 10.1089/dna.2013.2204     Document Type: Article

References (38)

1. Braun, N., Grone, H.J., and Schena, F.P. (2009). Immunological and non-immunological mechanisms of proteinuria. Minerva Urol Nefrol 61, 385-396.
2. Centers for Disease Control and Prevention (CDC). (2005). Incidence of end-stage renal disease among persons with diabetes - United States, 1990-2002. MMWR Morb Mortal Wkly Rep 54, 1097-1100.
3. Chiarelli, F., Gaspari, S., and Marcovecchio, M.L. (2009). Role of growth factors in diabetic kidney disease. Horm Metab Res 41, 585-593.
4. Conway, B.R., and Maxwell, A.P. (2009). Genetics of diabetic nephropathy: are there clues to the understanding of common kidney diseases? Nephron Clin Pract 112, c213-c221.
5. di Giovine, F.S., Takhsh, E., Blakemore, A.I., and Duff, G.W. (1992). Single base polymorphism at - 511 in the human interleukin- 1 beta gene (IL1 beta). Hum Mol Genet 1, 450.
6. Foley, R.N., and Collins, A.J. (2009). The growing economic burden of diabetic kidney disease. Curr Diab Rep 9, 460-465.
7. Freedman, B.I., Bostrom, M., Daeihagh, P., and Bowden, D.W. (2007). Genetic factors in diabetic nephropathy. Clin J Am Soc Nephrol 2, 1306-1316.
8. Freedman, B.I., Bowden, D.W., Sale, M.M., Langefeld, C.D., and Rich, S.S. (2006). Genetic susceptibility contributes to renal and cardiovascular complications of type 2 diabetes mellitus. Hypertension 48, 8-13. (Pubitemid 44297513)
9. Genuth, S., Alberti, K.G., Bennett, P., Buse, J., Defronzo, R., Kahn, R., Kitzmiller, J., Knowler, W.C., Lebovitz, H., Lernmark, A., Nathan, D., Palmer, J., Rizza, R., Saudek, C., Shaw, J., Steffes, M., Stern, M., Tuomilehto, J., and Zimmet, P. (2003). Follow-up report on the diagnosis of diabetes mellitus. Diabetes Care 26, 3160-3167. (Pubitemid 37339514)
10. Gruden, G., Perin, P.C., and Camussi, G. (2005). Insight on the pathogenesis of diabetic nephropathy from the study of podocyte and mesangial cell biology. Curr Diabetes Rev 1, 27-40.
11. Hall, S.K., Perregaux, D.G., Gabel, C.A., Woodworth, T., Durham, L.K., Huizinga, T.W., Breedveld, F.C., and Seymour, A.B. (2004). Correlation of polymorphic variation in the promoter region of the interleukin-1 beta gene with secretion of interleukin-1 beta protein. Arthritis Rheum 50, 1976-1983. (Pubitemid 38725110)
12. Huang, J., and Siragy, H.M. (2009). Glucose promotes the production of interleukine-1beta and cyclooxygenase-2 in mesangial cells via enhanced (Pro)renin receptor expression. Endocrinology 150, 5557-5565.
13. Lee, S.H., Ihm, C.G., Sohn, S.D., Lee, T.W., Kim, M.J., Koh, G., Oh, S.J., Woo, J.T., Kim, S.W., Kim, J.W., Kim, Y.S., Lee, B.C., Kim, S.D., Cho, B.S., Lee, H.J., and Chung, J.H. (2004). Polymorphisms in interleukin-1 beta and Interleukin- 1 receptor antagonist genes are associated with kidney failure in Korean patients with type 2 diabetes mellitus. Am J Nephrol 24, 410-414. (Pubitemid 39279382)
14. Liu, Z.H., Striker, G.E., Stetler-Stevenson, M., Fukushima, P., Patel, A., and Striker, L.J. (1996). TNF-alpha and IL-1 alpha induce mannose receptors and apoptosis in glomerular mesangial but not endothelial cells. Am J Physiol 270, C1595- C1601.
15. Loughrey, B.V., Maxwell, A.P., Fogarty, D.G., Middleton, D., Harron, J.C., Patterson, C.C., Darke, C., and Savage, D.A. (1998). An interluekin 1B allele, which correlates with a high secretor phenotype, is associated with diabetic nephropathy. Cytokine 10, 984-988. (Pubitemid 29080694)
16. Lovett, D.H., Szamel, M., Ryan, J.L., Sterzel, R.B., Gemsa, D., and Resch, K. (1986). Interleukin 1 and the glomerular mesangium. I. Purification and characterization of a mesangial cell-derived autogrowth factor. J Immunol 136, 3700-3705. (Pubitemid 16122066)
17. Maeda, S. (2008). Do inflammatory cytokine genes confer susceptibility to diabetic nephropathy? Kidney Int 74, 413-415.
18. Navarro-Gonzalez, J.F., and Mora-Fernandez, C. (2008). The role of inflammatory cytokines in diabetic nephropathy. J Am Soc Nephrol 19, 433-442. (Pubitemid 351355386)
19. Nicklin, M.J., Barton, J.L., Nguyen, M., FitzGerald, M.G., Duff, G.W., and Kornman, K. (2002). A sequence-based map of the nine genes of the human interleukin-1 cluster. Genomics 79, 718-725. (Pubitemid 34499488)
20. Nicklin, M.J., Weith, A., and Duff, G.W. (1994). A physical map of the region encompassing the human interleukin-1 alpha, interleukin-1 beta, and interleukin-1 receptor antagonist genes. Genomics 19, 382-384. (Pubitemid 24059336)
21. Pociot, F., Molvig, J., Wogensen, L., Worsaae, H., and Nerup, J. (1992). A TaqI polymorphism in the human interleukin-1 beta (IL-1 beta) gene correlates with IL-1 beta secretion in vitro. Eur J Clin Invest 22, 396-402.
22. Quinn, M., Angelico, M.C., Warram, J.H., and Krolewski, A.S. (1996). Familial factors determine the development of diabetic nephropathy in patients with IDDM. Diabetologia 39, 940-945. (Pubitemid 26249113)
23. Rogus, J., Beck, J.D., Offenbacher, S., Huttner, K., Iacoviello, L., Latella, M.C., de Gaetano, M., Wang, H.Y., Kornman, K.S., and Duff, G.W. (2008). IL1B gene promoter haplotype pairs predict clinical levels of interleukin-1beta and C-reactive protein. Hum Genet 123, 387-398.
24. Steinkasserer, A., Spurr, N.K., Cox, S., Jeggo, P., and Sim, R.B. (1992). The human IL-1 receptor antagonist gene (IL1RN) maps to chromosome 2q14-q21, in the region of the IL-1 alpha and IL-1 beta loci. Genomics 13, 654-657.
25. Strojek, K., Grzeszczak, W., Morawin, E., Adamski, M., Lacka, B., Rudzki, H., Schmidt, S., Keller, C., and Ritz, E. (1997). Nephropathy of type II diabetes: evidence for hereditary factors? Kidney Int 51, 1602-1607.
26. Tarnow, L., Pociot, F., Hansen, P.M., Rossing, P., Nielsen, F.S., Hansen, B.V., and Parving, H.H. (1997). Polymorphisms in the interleukin-1 gene cluster do not contribute to the genetic susceptibility of diabetic nephropathy in Caucasian patients with IDDM. Diabetes 46, 1075-1076. (Pubitemid 27221011)
27. Tesch, G.H. (2008). MCP-1/CCL2: a new diagnostic marker and therapeutic target for progressive renal injury in diabetic nephropathy. Am J Physiol Renal Physiol 294, F697-F701.
28. The Diabetes Control and Complications Trial Research Group. (1997). Clustering of long-term complications in families with diabetes in the diabetes control and complications trial. Diabetes 46, 1829-1839.
29. Thomas, M.C., Groop, P.H., and Tryggvason, K. (2012). Towards understanding the inherited susceptibility for nephropathy in diabetes. Curr Opin Nephrol Hypertens 21, 195-202.
30. Van Dijk, P.C., Jager, K.J., Stengel, B., Gronhagen-Riska, C., Feest, T.G., and Briggs, J.D. (2005). Renal replacement therapy for diabetic end-stage renal disease: data from 10 registries in Europe (1991-2000). Kidney Int 67, 1489-1499.
31. Weir, B.S. (1996). Genetic Data Analysis II: Methods for Discrete Population Genetic Data (Sinauer Associates, Sunderland, MA).
32. Zintzaras, E. (2010). The generalized odds ratio as a measure of genetic risk effect in the analysis and meta-analysis of association studies. Stat Appl Genet Mol Biol 9, Article21.
33. Zintzaras, E., Kitsios, G., and Stefanidis, I. (2006). Endothelial NO synthase gene polymorphisms and hypertension: a metaanalysis. Hypertension 48, 700-710. (Pubitemid 44843875)
34. Zintzaras, E., and Lau, J. (2008a). Synthesis of genetic association studies for pertinent gene-disease associations requires appropriate methodological and statistical approaches. J Clin Epidemiol 61, 634-645. (Pubitemid 351766746)
35. Zintzaras, E., and Lau, J. (2008b). Trends in meta-analysis of genetic association studies. J Hum Genet 53, 1-9.
36. Zintzaras, E., and Santos, M. (2011). Estimating the mode of inheritance in genetic association studies of qualitative traits based on the degree of dominance index. BMC Med Res Methodol 11, 171.
37. Zintzaras, E., and Santos, M. (2012). Performance of MAX test and degree of dominance index in predicting the mode of inheritance. Stat Appl Genet Mol Biol 11, Article-6115.
38. Zintzaras, E., and Stefanidis, I. (2005). Association between the GLUT1 gene polymorphism and the risk of diabetic nephropathy: a meta-analysis. J Hum Genet 50, 84-91. (Pubitemid 40468854)